MEDIUM confidence: 100% data completeness, but the composite (56) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $12.2B— | $11.9B-2.0% | $11.8B-1.5% | $18.6B+57.6% | $22.1B+19.1% |
| EPS (dil.) | $1.46— | $-0.58-139.7% | $-3.00n/m | $2.86n/m | $6.41+124.1% |
| Free Cash Flow | $2.6B— | $1.1B-58.5% | $97M-91.1% | $3.0B+2952.6% | $7.3B+146.5% |
| Gross Margin | 19.5% | 17.9%-1.5pp | 9.9%-8.0pp | 34.6%+24.7pp | 49.8%+15.2pp |
| Operating Margin | 15.7% | 13.6%-2.2pp | 5.5%-8.0pp | 31.0%+25.5pp | 46.9%+15.9pp |
| Net Margin | 9.6% | -3.8%-13.4pp | -21.4%-17.6pp | 18.0%+39.5pp | 32.1%+14.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $139 (last qtr, 11 analysts) → $137 (last mo, 6) (-1.5%).
Buy-rated share 78% → 87% over ~3 months (+9pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.05 | $2.10 | +2.4% |
| Apr 2026 | $2.07 | $2.90 | +40.1% |
| Feb 2026 | $2.07 | $2.52 | +21.7% |
| Oct 2025 | $1.44 | $1.71 | +18.8% |
| Jul 2025 | $0.91 | $1.43 | +58.0% |
| Apr 2025 | $0.92 | $1.25 | +36.5% |
| Feb 2025 | $1.11 | $1.40 | +26.1% |
| Oct 2024 | $0.86 | $0.81 | -5.8% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$10.1M over 180 days (0 open-market buys, 16 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of -2.1%/yr (revenue basis).
Base free cash flow $3.5B (avg FY2023–FY2025; latest year $7.3B) · equity value $120.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 56 for Newmont Corporation suggests a neutral outlook, driven by strong profitability scores, with a return on equity near 25% and operating margin of 51.4%, which lifts the overall score. However, the value category scores lower due to a P/E of 14.4 and EV/EBITDA of 8.1, indicating the stock trades at a moderate premium. The stock exhibits strong momentum, with a 12-month return of 66.0%, but this is somewhat offset by a recent 3-month decline of 3.8%.